SCHEMBL30139616

SCHEMBL30139616

c1ccc(-c2ccc(-c3ccc4oc5ccccc5c4c3-c3ccc(-c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC14B O60729 2/20 0.43
CDC14A Q9UNH5 2/20 0.43
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
PLA2G2A P14555 5/20 0.42
PLA2G4A P47712 5/20 0.42
WEE1 P30291 1/20 0.42
PTPN1 P18031 3/20 0.40
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 3/20 0.38
CYP3A4 P08684 3/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
GLA P06280 1/20 0.38
PGAM1 P18669 1/20 0.38
MAOA P21397 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18382693 0.97 CDC14B (0.41) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL12203193 0.96 CA1 (0.45) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL18382692 0.95 CDC14B (0.42) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL19764762 0.95 CDC14B (0.42) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL26491352 0.92 CDC14B (0.40) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL27287766 0.91 CDC14B (0.38) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL19764823 0.90 CA1 (0.41) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL26491405 0.90 CA1 (0.41) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL26761801 0.90 PLA2G2A (0.45) CDC14BCDC14ACA1CA2PLA2G2A
SCHEMBL19764764 0.89 PLA2G2A (0.40) CDC14BCDC14ACA1CA2PLA2G2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588117-B2 Materials for electronic devices MERCK PATENT GMBH (DE) 2023-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11588117-B2 Materials for electronic devices EPHB3, EPHA3, EPHB4 CDC14B 2489/4885CDC14A 2342/4885CA1 3240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.